摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl]ethanol

中文名称
——
中文别名
——
英文名称
1-[3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl]ethanol
英文别名
——
1-[3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl]ethanol化学式
CAS
——
化学式
C13H16F2O3
mdl
——
分子量
258.265
InChiKey
UXDRFJLTQPPSEO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    18
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    38.7
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • 7-(3',4'-Dialkoxyphenyl)-[1,2,4]-Triazolo[1,5-A]Pyrimidine Compounds, Process for Preparing Thereof, and Pharmaceutical Composition for Treating or Preventing Asthma, Chronic Obstructive Pulmonary Disease, Arthritis, Atopic Dermatitis, Tumor and Degenerative Brain Diseases Comprising the Same
    申请人:Jeon Dong Ju
    公开号:US20100105704A1
    公开(公告)日:2010-04-29
    The present invention relates to novel 7-(3′,4′-dialkoxyphenyl)-[1,2,4]-triazolo[1,5-a]pyrimidine compounds or pharmaceutically acceptable salts thereof, a process for preparing the same, and pharmaceutical compositions for treating or preventing inflammatory diseases including asthma and chronic obstructive pulmonary disease, arthritis, atopic dermatitis, cancers including leukemia, and degenerative brain diseases including Alzheimer's disease, depression and memory impairment, which comprises the same as an active ingredient.
    本发明涉及新型7-(3′,4′-二烷氧基苯基)-[1,2,4]-三唑并[1,5-a]嘧啶化合物或其药学上可接受的盐,制备该化合物的方法,以及制备药物组合物,用于治疗或预防炎症性疾病,包括哮喘和慢性阻塞性肺疾病、关节炎、特应性皮炎、包括白血病在内的癌症,以及包括阿尔茨海默病、抑郁症和记忆力减退在内的退行性脑疾病,其中该化合物作为活性成分。
  • 7-(3′,4′-Dialkoxyphenyl)[1,2,4]-triazolo[1,5-A]pyrimidine compounds, process for preparing thereof, and pharmaceutical composition for treating or preventing asthma, chronic obstructive pulmonary disease, arthritis, atopic dermatitis, tumor and degenerative brain diseases comprising the same
    申请人:Korea Research Institute of Chemical Technology
    公开号:US08143262B2
    公开(公告)日:2012-03-27
    The present invention relates to novel 7-(3′,4′-dialkoxyphenyl)-[1,2,4]-triazolo[1,5-a]pyrimidine compounds or pharmaceutically acceptable salts thereof, a process for preparing the same, and pharmaceutical compositions for treating or preventing inflammatory diseases including asthma and chronic obstructive pulmonary disease, arthritis, atopic dermatitis, cancers including leukemia, and degenerative brain diseases including Alzheimer's disease, depression and memory impairment, which comprises the same as an active ingredient.
    本发明涉及一种新型7-(3′,4′-二烷氧基苯基)-[1,2,4]-三唑并[1,5-a]嘧啶化合物或其药学上可接受的盐,以及制备它们的方法和制备药物组合物以治疗或预防包括哮喘和慢性阻塞性肺疾病、关节炎、特应性皮炎、包括白血病在内的癌症和包括阿尔茨海默病、抑郁症和记忆障碍在内的退行性脑疾病的药物组合物,其中包括它们作为活性成分。
  • US8143262B2
    申请人:——
    公开号:US8143262B2
    公开(公告)日:2012-03-27
  • [EN] 7-(3',4'-DIALKOXYPHENYL)-[1,2,4]-TRIAZOLO[1,5-A]PYRIMIDINE COMPOUNDS, PROCESS FOR PREPARING THEREOF, AND PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING ASTHMA, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ARTHRITIS, ATOPIC DERMATITIS, TUMOR AND DEGE<br/>[FR] COMPOSÉS {7-(3 ', 4 '-DIALKOXYPHÉNYL) - [1,2,4]-TRIAZOLO [1,5-A] PYRIMIDINE LEUR PROCÉDÉ DE PRÉPARATION ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, POUR LE TRAITEMENT OU LA PREVENTION DE L'ASTHME, DE LA BRONCHOPNEUMOPATHIE CHRONIQUE OBSTRUCTIVE, D
    申请人:KOREA RES INST CHEM TECH
    公开号:WO2008117943A1
    公开(公告)日:2008-10-02
    [EN] The present invention relates to novel 7-(3',4'-dialkoxyphenyl)-[1,2,4]-triazolo[1,5-a]pyrimidine compounds or pharmaceutically acceptable salts thereof, a process for preparing the same, and pharmaceutical compositions for treating or preventing inflammatory diseases including asthma and chronic obstructive pulmonary disease, arthritis, atopic dermatitis, cancers including leukemia, and degenerative brain diseases including Alzheimer's disease, depression and memory impairment, which comprises the same as an active ingredient.
    [FR] L'invention porte sur de nouveaux composés 7-(3 ', 4 '-dialcoxyphényl) - [1,2,4]-triazolo [1,5-a] pyrimidine ou ses sels pharmaceutiquement acceptables, sur leur procédé de préparation et sur des compositions pharmaceutiques comprenant lesdits composés comme principes actifs, pour le traitement ou la prévention de maladies inflammatoires dont l'asthme, la bronchopneumopathie chronique obstructive, l'arthrite, la dermatite atopique, des cancers dont la leucémie et des maladies cérébrales dégénératives dont la maladie d'Alzheimer, les dépressions et les troubles de la mémoire.
  • WO2008/117943
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多